MoneyWorks4Me

Fermenta Biotech informs about investor meeting

17 Jun 2026 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Fermenta Biotech has informed that the Company, through its officials, will be participating in meeting(s) with investors on June 22, 2026 in Mumbai (One-to-one). The company has further informed that the Press Release dated May 26, 2026 regarding audited Financial results for the year ended March 31, 2026 and relevant Investor Presentation proposed to be discussed with investor(s) in the above interaction is uploaded on the website of the Company: www.fermentabiotech.com and on BSE’ website: www.bseindia.com. No unpublished price sensitive information (UPSI) is intended to be discussed during the interaction.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..